SCHEMBL1717560

SCHEMBL1717560

Cc1c[c]cc2c1OC(C)(CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C=C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.39
▸ MAPT P10636 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GSTP1 P09211 1/20 0.35
▸ TTPA P49638 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PTPN1 P18031 2/20 0.33
▸ PDE4A P27815 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ AKT1 P31749 5/20 0.32
▸ GSTO1 P78417 2/20 0.32
▸ NR1I2 O75469 1/20 0.32
▸ PSEN1 P49768 2/20 0.31
▸ PDPK1 O15530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1717558 1.00 LMNA (0.39) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL9285268 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21131789 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21931412 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21931411 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21929591 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21929589 0.73 LMNA (0.55) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL28448490 0.71 LMNA (0.40) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL21754694 0.70 LMNA (0.48) LMNAMAPTMEN1KMT2AGSTP1
SCHEMBL2635649 0.69 LMNA (0.43) LMNAMAPTMEN1KMT2AGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420610-B2 Polyunsaturated compounds, method for preparing same and compositions containing the same PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-04-16 — — US claimed
EP-1968993-B1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME FABRE PIERRE DERMO COSMETIQUE (FR) 2012-01-11 — — EP claimed
US-20100168045-A1 Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-07-01 — — US claimed
JP-2009519298-A — — 2009-05-14 — — JP claimed
EP-1968993-A1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME Pierre Fabre Dermo-Cosmetique (FR) 2008-09-17 — — EP claimed
WO-2007068745-A1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME PIERRE FABRE DERMO-COSMETIQUE (FR) 2007-06-21 — — WO claimed
US-8420610-B2 Polyunsaturated compounds, method for preparing same and compositions containing the same PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-04-16 — — US disclosed
EP-1968993-B1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME FABRE PIERRE DERMO COSMETIQUE (FR) 2012-01-11 — — EP disclosed
US-20100168045-A1 Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-07-01 — — US disclosed
EP-1968993-A1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME Pierre Fabre Dermo-Cosmetique (FR) 2008-09-17 — — EP disclosed
WO-2007068745-A1 NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME PIERRE FABRE DERMO-COSMETIQUE (FR) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168045-A1 Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same CBR3, CBR1, DECR1 LMNA 1054/4885MAPT 4344/4885MEN1 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback